# 3BNC117 and 10-1074 in HIV Uninfected Adults

> **NCT02824536** · PHASE1 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 24 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** 3BNC117
- **DRUG:** 10-1074
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02824536
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-23
- **Primary completion:** 2018-01-09
- **Final completion:** 2018-01-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02824536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02824536, "3BNC117 and 10-1074 in HIV Uninfected Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02824536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*